Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern

Radiology

Volumn 196, Issue 2, 1995, Pages 433-437

  Laya, Mary B ^a   Gallagher, J Chris ^b   Schreiman, Judith S ^c   Larson, Eric B ^a   Watson, Patrice ^d   Weinstein, Louis ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

^e MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Breast neoplasms, radiography; Breast radiography; Breast, parenchymal pattern; Cancer screening; Hormones

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029127978     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.196.2.7617857     Document Type: Article

References (40)

1. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325:756-762.
2. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991; 265:1861-1867.
3. Lobo RA. Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol 1990; 75(suppl):18-25.
4. Psaty BM, Heckbert SR, Atkins D, Siscovick DS, Koepsell TD. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. Arch Intern Med 1993; 153:1421-1427.
5. Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980; 303:1195-1198.
6. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985; 102:319-324.
7. Riggs BL, Melton LJ. The prevention and treatment of osteoporosis. N Engl J Med 1992; 327:620-627.
8. Steinberg KK, Thaker SB, Smith J, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991; 265:1985-1990.
9. DuPont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991; 151:67-72.
10. VoherH. Menopausal mammary involution. In: Voher H. The Breast. New York, NY: Academic Press, 1974; 215-217.
11. Longacre TA, Bartow SA. A correlative morphologic study of the human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986; 10:382-393.
12. Grove JS, Goodman MJ, Gilbert FI, et al. Factors associated with mammographic pattern. Br J Radiol 1985; 58:21-25.
13. Whitehouse GH, Leinster SJ. The variation of breast parenchymal patterns with age. Br J Radiol 1985; 58:315-318.
14. Saftlas AF, Hoover RN, Brinton LA, et al. Mammographic densities and risk of breast cancer. Cancer 1991; 67:2833-2838.
15. Cyrlak D, Wong CH. Mammographic changes in post-menopausal women undergoing hormonal replacement therapy. AJR 1993; 161:1177-1183.
16. Peck DR, Lowman RM. Estrogen and the postmenopausal breast. JAMA 1978; 240: 1733-1735.
17. Bland KI, Buchanan JB, Weisberg BF, Hagan TA, Gray LA. The effects of exogenous estrogen replacement therapy of the breast: breast cancer risk and mammographic parenchymal pattern. Cancer 1980; 45:3027-3033.
18. Buchanan JB, Weisburg BF, Sandoz JP, et al. Selected prognostic variables for mammographic parenchymal patterns. Cancer 1981; 47:2135-2137.
19. Berkvist L, Tabar L, Adami H, et al. Mammographic parenchymal pattern in women receiving non-contraceptive estrogen treatment. Am J Epidemiol 1989; 130:503-510.
20. Kaufman Z, Garstin WI, Hayes R, et al. The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 1991; 43:389-392.
21. Stomper PC, Van Voorhis BJ, Ravnikar VA, et al. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990; 174:487-490.
22. Berkowitz JE, Gatewood OMB, Goldblum LE, Gayler BW. Hormonal replacement therapy: mammographic manifestations. Radiology 1990; 174:199-201.
23. McNicholas MMJ, Heneghan JP, Milner MH, et al. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. AJR 1994; 163:311-315.
24. Weinstein L, Bewtra C, Gallagher JC. Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient. Am J Obstet Gynecol 1990; 162:1534-1542.
25. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR 1976; 126:1130-1139.
26. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR 1987; 148: 1087-1092.
27. Gravelle IH, Bulstrode JC, Bulbrook RD. The relationship between radiologic patterns of the breast and body weight and height. Br J Radiol 1982; 55:23-25.
28. Grove JS, Goodman MJ, Gilbert FI, et al. Factors associated with mammographic pattern. Br J Radiol 1985; 58:21-25
29. Whitehouse GH, Leinster SJ. The variation of breast parenchymal patterns with age. Br J Radiol 1985; 58:315-318.
30. De Stavola BL, Gravelle IH, Wang DY, et al. Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. Int J Epidemiol 1990; 19:247-254.
31. Hart BL, Steinbock T, Mettler FA, et al. Age and race related changes in mammographic parenchymal patterns. Cancer 1989; 63:2537-2539.
32. Hormonal replacement therapy. American College of Obstetricians and Gynecologists technical bulletin no. 166. Washington, DC: American College of Obstetricians and Gynecologists, April 1992.
33. Jones KP. Estrogens and progestins: what to use and how to use it. Clin Obstet Gynecol 1992; 35:871-883.
34. Clarke CL, Sutherland RL. Progestin regulation of cellular proliferation. Endocr Rev 1990; 11:266-301.
35. Feig SA, Shaber GS, Patchefsky A, et al. Analysis of clinically occult and mammographically occult breast tumors. Am J Roentgenol 1977; 128:403-408.
36. Jackson VP, Hendrick RE, Feig SA, Kopans DB. Imaging of the radiographically dense breast. Radiology 1993; 188:297-301.
37. Ma L, Fishell E, Wright B, et al. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 1992; 84:781-785.
38. Fajardo LL, Hillman BJ, Frey C. Correlation between breast parenchymal patterns and mammographers′ certainty of diagnosis. Invest Radiol 1988; 23:505-508.
39. Warner E, Lockwood G, Math M, et al. The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev 1992; 16:67-72.
40. Goodwin PJ, Boyd NF. Mammographic parenchymal pattern and breast cancer risk: a critical appraisal of the evidence. Am J Epidemiol 1988; 6:1097-1108.